Trusted Partner in Calprotectin Testing
Smart, connected IBD Diagnostics and monitoring trusted worldwide for 30+ years.
Delivering Prognostic Insight Across the IBD Care Pathway
Calpro provides clinically validated calprotectin solutions that support faster, more reliable IBD monitoring. From rapid home testing to clinic‑based point‑of‑care monitoring and laboratory ELISA kits, our portfolio helps clinicians and patients make timely, informed decisions that can support reductions in unnecessary procedures and contribute to improved outcomes.
Rapid Self-Test & Point-of-Care Test
Quick and reliable calprotectin tests for home and point-of-care, with results in minutes
Laboratory Assays
High-precision calprotectin assays for accurate IBD diagnosis and monitoring
Extraction Device
Easy and hygienic stool sample preparation for dependable calprotectin testing
Our complete portfolio
Calprotectin Solutions
– From Lab to Home
We deliver total solution for calprotectin diagnostics and monitoring tools: CalproLab® ELISA and RUO kits with Calpro Easy Extract® devices for laboratories, CalproSmart® Office + app for point-of-care use providing quantitative results in under 20 minutes, and CalproSmart® Self-Test for home monitoring with clinician connectivity.
Secure API and DeepLink integrations connect CalproSmart® data to HIS and LIMS platforms and apps, enabling real time data that can be combined with patient reported outcome measures to support IBD programs throughout Europe.
Evidence-based biomarker
Why Calprotectin?
Recommended by ECCO, NICE, and AGA guidelines, calprotectin is an early detector of inflammation, differentiates IBD from IBS, and provides objective diagnostic and prognostic information. By enabling sub‑clinical detection of flare, early intervention, and close‑to‑real‑time mucosal healing assessment, calprotectin testing can support both immediate clinical decisions and long‑term disease management.
Who we are
Global Specialists Dedicated to Advancing Calprotectin in IBD Care
Calpro is a Norwegian biotechnology company focused exclusively on calprotectin, the leading non-invasive biomarker for intestinal inflammation. We develop, manufacture, and distribute solutions to help clinicians and patients make timely decisions and support prognostic assessment.
Hospitals, laboratories, clinicians, and patients rely on Calpro’s portfolio, which includes the CalproSmart® Self-Test, CalproLab® ELISA kits, and Calpro® Easy Extract sample preparation, to support early detection of inflammation and effective monitoring of disease progression.
Get Calprotectin Research, Webinars, and Event Alerts
Latest News & Events
-
From Reactive to Proactive: How Home Testing Is Redefining IBD Care in the NHS England
Healthcare systems everywhere are under pressure, and IBD care is no exception. Rising patient volumes, limited resources, and delayed diagnostics make it difficult for clinicians to stay ahead of a fluctuating disease. According to Lianne Lewis, IBD Nurse Specialist at Milton Keynes University Hospital NHS Foundation Trust, home-based calprotectin testing is changing that, shifting IBD…
-
Meet Calpro’s Team at BSG LIVE ’26 Liverpool
BSG LIVE ’26 · LEX Liverpool · 22–25 June 2026 Meet Our Team – Heading to BSG Liverpool In June 22nd, Calpro will be at BSG LIVE ’26 in Liverpool – one of the UK’s most important gatherings for gastroenterology and IBD care. We’re sending two of our very best. Before you make it to…
-
IBD Awareness Day: Monitoring Is Where It Matters
Every year on May 19, World IBD Day brings attention to the reality of living with Crohn’s disease and ulcerative colitis. More than ten million people worldwide manage these conditions every day, navigating flares, treatment decisions, and the uncertainty of a disease with no cure. Awareness matters. But for clinicians treating IBD, awareness is not…